Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Paus

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 29, 1988
An enzyme antigen immunoassay for the determination of neuron-specific enolase in serum samplesK Sorensen, U Brodbeck, E Paus, et al.
The Prostate|February 15, 2001
Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancerW Lilleby, E Paus, E Skovlund, et al.
British Journal of Urology|June 1, 1987
The diagnostic value of human chorionic gonadotrophin in patients with testicular seminomaE Paus, S D Fosså, T Risberg, et al.
British Journal of Urology|April 1, 1995
Increase of serum prostatic specific antigen and clinical progression in pN + MO prostate cancerD Josefsen, H Waehre, E Paus, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
Specificity and affinity of 30 monoclonal antibodies against alpha-fetoproteinK Nustad, E Paus, B Kierulf, et al.
The Journal of Urology|March 1, 1988
High frequency of incomplete human chorionic gonadotropin in patients with testicular seminomaE Paus, A Fosså, S D Fosså, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 20, 1994
[Tumor marker analyses--valuable tools if used correctly]O P Børmer, E Paus, K Nustad, et al.
British Journal of Urology|February 1, 1992
Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatmentS D Fosså, E Paus, M Lindegaard, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2000
Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigenJ Leinonen, W M Zhang, E Paus, et al.
European Urology|January 1, 1992
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancerH Waehre, E H Wanderaas, E Paus, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 29, 1988
An enzyme antigen immunoassay for the determination of neuron-specific enolase in serum samplesK Sorensen, U Brodbeck, E Paus, et al.
The Prostate|February 15, 2001
Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancerW Lilleby, E Paus, E Skovlund, et al.
British Journal of Urology|June 1, 1987
The diagnostic value of human chorionic gonadotrophin in patients with testicular seminomaE Paus, S D Fosså, T Risberg, et al.
British Journal of Urology|April 1, 1995
Increase of serum prostatic specific antigen and clinical progression in pN + MO prostate cancerD Josefsen, H Waehre, E Paus, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
Specificity and affinity of 30 monoclonal antibodies against alpha-fetoproteinK Nustad, E Paus, B Kierulf, et al.
The Journal of Urology|March 1, 1988
High frequency of incomplete human chorionic gonadotropin in patients with testicular seminomaE Paus, A Fosså, S D Fosså, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 20, 1994
[Tumor marker analyses--valuable tools if used correctly]O P Børmer, E Paus, K Nustad, et al.
British Journal of Urology|February 1, 1992
Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatmentS D Fosså, E Paus, M Lindegaard, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2000
Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigenJ Leinonen, W M Zhang, E Paus, et al.
European Urology|January 1, 1992
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancerH Waehre, E H Wanderaas, E Paus, et al.
Pageof 7